Items 241 to 250 of 303 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2-Methyltetrahydrothiophen-3-one | 13679-85-1 | sc-265828 sc-265828A | 5 g 25 g | $120.00 $548.00 | ||
2-Methyltetrahydrothiophen-3-one exhibits notable antiviral characteristics, primarily through its sulfur-containing heterocyclic structure. This compound can engage in specific molecular interactions with viral enzymes, potentially disrupting their catalytic activity. Its unique ring system may also influence the stability of viral RNA, hindering replication. Additionally, the compound's physical properties, such as its lipophilicity, may enhance membrane permeability, facilitating its interaction with viral targets. | ||||||
3,5,6-Trichloro-[1,2,4]triazine | 873-41-6 | sc-335875 | 1 g | $575.00 | ||
3,5,6-Trichloro-[1,2,4]triazine demonstrates intriguing antiviral properties through its highly reactive triazine ring, which can form covalent bonds with nucleophilic sites on viral proteins. This reactivity may inhibit essential viral functions by modifying key amino acids, disrupting protein folding and function. The compound's electron-withdrawing chlorine substituents enhance its electrophilicity, promoting selective interactions with viral targets. Its stability under various conditions further supports its potential in antiviral applications. | ||||||
2,6-Bis[(4S)-(−)-isopropyl-2-oxazolin-2-yl]pyridine | 118949-61-4 | sc-251864 | 250 mg | $92.00 | ||
2,6-Bis[(4S)-(-)-isopropyl-2-oxazolin-2-yl]pyridine exhibits notable antiviral activity through its unique ligand-binding capabilities. The oxazoline moieties facilitate strong coordination with metal ions, potentially disrupting viral replication pathways. Its chiral centers contribute to selective interactions with viral enzymes, enhancing specificity. Additionally, the compound's planar pyridine core allows for effective π-π stacking with nucleic acids, further influencing viral activity. | ||||||
N-Boc-S-methyl-L-cysteine | 16947-80-1 | sc-269799 | 1 g | $143.00 | ||
N-Boc-S-methyl-L-cysteine demonstrates intriguing antiviral properties through its ability to form stable adducts with viral proteins. The presence of the N-Boc protecting group enhances its solubility and stability, allowing for efficient cellular uptake. Its thiol group can engage in redox reactions, potentially altering viral protein function. Furthermore, the compound's stereochemistry may influence its interaction dynamics, providing a unique mechanism for disrupting viral life cycles. | ||||||
Colominic acid sodium salt from Escherichia coli | 70431-34-4 | sc-239576 sc-239576A sc-239576B sc-239576C | 100 mg 1 g 17 g 20 g | $219.00 $1085.00 $10200.00 $12240.00 | 5 | |
Colominic acid sodium salt, derived from Escherichia coli, exhibits notable antiviral activity by modulating host cell signaling pathways. Its unique polysaccharide structure facilitates interactions with viral glycoproteins, potentially inhibiting viral entry. The compound's anionic nature enhances its binding affinity to positively charged viral surfaces, disrupting critical interactions. Additionally, its ability to form complexes with metal ions may influence viral replication processes, showcasing its multifaceted role in antiviral defense. | ||||||
1,3,5-Benzenetricarbonyl trichloride | 4422-95-1 | sc-251588 sc-251588A | 10 g 25 g | $57.00 $79.00 | ||
1,3,5-Benzenetricarbonyl trichloride, an acid halide, demonstrates intriguing reactivity through its electrophilic carbonyl groups, which can engage in nucleophilic attack by viral proteins. This interaction may lead to the modification of viral structures, potentially impairing their function. The compound's high reactivity allows for rapid formation of acyl derivatives, which can alter the stability of viral components, thereby influencing viral lifecycle dynamics. Its unique molecular architecture may also facilitate selective interactions with specific viral targets, enhancing its potential efficacy in disrupting viral processes. | ||||||
(4-Chlorophenylsulfonyl)acetone | 5000-48-6 | sc-397858 | 1 g | $37.00 | ||
(4-Chlorophenylsulfonyl)acetone exhibits notable reactivity due to its sulfonyl group, which can engage in strong interactions with nucleophilic sites on viral proteins. This compound's ability to form stable adducts may hinder viral replication by altering protein conformation. Additionally, its unique electronic properties can enhance the rate of reaction with target molecules, potentially leading to significant disruptions in viral assembly and function. The compound's structural features may also allow for selective targeting of specific viral pathways, further influencing its antiviral potential. | ||||||
4-Hydroxy-3,5-dimethoxybenzyl alcohol | 530-56-3 | sc-397919 | 1 g | $52.00 | ||
4-Hydroxy-3,5-dimethoxybenzyl alcohol demonstrates intriguing antiviral properties through its ability to interact with viral enzymes and proteins. The presence of hydroxyl and methoxy groups enhances its solubility and facilitates hydrogen bonding, which can disrupt viral entry or replication processes. Its unique molecular structure allows for specific binding interactions, potentially inhibiting critical viral functions and altering the dynamics of viral life cycles. | ||||||
4-Hydroxy-3,5-dimethylbenzoic acid | 4919-37-3 | sc-397923 | 1 g | $60.00 | ||
4-Hydroxy-3,5-dimethylbenzoic acid exhibits notable antiviral characteristics by engaging in specific molecular interactions that can modulate viral activity. The presence of hydroxyl groups contributes to its ability to form strong hydrogen bonds, potentially stabilizing or destabilizing viral structures. Its distinct aromatic framework may influence electron distribution, affecting the reactivity of viral components and altering their functional pathways, thereby impacting viral proliferation. | ||||||
Cytarabine-13C3 | sc-217994 | 2.5 mg | $1224.00 | 1 | ||
Cytarabine-13C3 demonstrates intriguing antiviral properties through its unique structural modifications, which enhance its interaction with viral nucleic acids. The incorporation of carbon isotopes alters its kinetic behavior, potentially influencing the rate of incorporation into viral RNA or DNA. This isotopic labeling may also affect the stability of the resulting nucleic acid complexes, leading to altered replication dynamics and viral assembly processes. Its distinct molecular conformation may further facilitate selective binding to viral enzymes, disrupting their activity. | ||||||